Wolverine Asset Management LLC Buys Shares of 92,968 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Wolverine Asset Management LLC bought a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 92,968 shares of the pharmacy operator’s stock, valued at approximately $833,000.

Other institutional investors have also added to or reduced their stakes in the company. Iron Horse Wealth Management LLC boosted its stake in Walgreens Boots Alliance by 162.5% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 1,081 shares during the period. Continuum Advisory LLC grew its holdings in shares of Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 1,020 shares during the period. Sentry Investment Management LLC bought a new stake in shares of Walgreens Boots Alliance in the third quarter worth $30,000. Finally, Eastern Bank bought a new stake in shares of Walgreens Boots Alliance in the third quarter worth $33,000. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $9.01 on Wednesday. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $7.79 billion, a P/E ratio of -0.94, a P/E/G ratio of 1.19 and a beta of 0.69. Walgreens Boots Alliance, Inc. has a 12 month low of $8.22 and a 12 month high of $27.05. The business’s 50-day moving average is $9.18 and its 200 day moving average is $12.08.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.67 earnings per share. On average, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 annualized dividend and a yield of 11.10%. Walgreens Boots Alliance’s payout ratio is currently -9.99%.

Analysts Set New Price Targets

Several analysts recently commented on WBA shares. UBS Group lifted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. TD Cowen lowered their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Evercore ISI lifted their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research report on Wednesday, October 16th. Finally, JPMorgan Chase & Co. lowered their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.